Medicine
Alfuzosin 10 mg extended-release tablet
Alfuzosin 10 mg extended-release tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 0 to 25 0 C (68 0 to 77 0 F). Protect from light and moisture.
Key facts
- Active ingredient (INN)
- Alfuzosin
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 43 more
- Manufacturers
- Aurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaUnichem LaboratoriesIndiaBryant Ranch PrepackRising Pharma HoldingsExelan PharmaceuticalsApotex9 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20 0 to 25 0 C (68 0 to 77 0 F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04CA01 Alfuzosin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 November 2011
- Identifiers
- RxCUI 861132DailyMed set ID ffbd22eb-9df5-e0ad-e053-6294a90a7d4e, 43675e9d-a361-4109-9ae1-54d80580fbbd, 3a541efa-9eed-4a27-b602-7999fc6f59aa +12NDC 51655-967, 57237-114, 72162-1449 +12Application ANDA203192, ANDA079060, ANDA079057 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 9 labelers. The register lists 46 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated, extended release in 1 bottle | 84386-153-01 | Aurobindo PharmaIndia | 1 July 2026 |
| 500 tablet, film coated, extended release in 1 bottle | 84386-153-05 | Aurobindo PharmaIndia | 1 July 2026 |
| 30 tablet, film coated, extended release in 1 bottle | 84386-153-30 | Aurobindo PharmaIndia | 1 July 2026 |
| 90 tablet, film coated, extended release in 1 bottle | 84386-153-90 | Aurobindo PharmaIndia | 1 July 2026 |
| 1000 tablet, film coated, extended release in 1 bottle | 84386-153-99 | Aurobindo PharmaIndia | 1 July 2026 |
| 100 tablet, extended release in 1 bottle | 47335-956-08 | Sun Pharmaceutical IndustriesIndia | 22 November 2011 |
| 1000 tablet, extended release in 1 bottle | 47335-956-18 | Sun Pharmaceutical IndustriesIndia | 22 November 2011 |
| 90 tablet, extended release in 1 bottle | 47335-956-81 | Sun Pharmaceutical IndustriesIndia | 22 November 2011 |
| 30 tablet, extended release in 1 bottle | 47335-956-83 | Sun Pharmaceutical IndustriesIndia | 22 November 2011 |
| 100 tablet, extended release in 1 bottle | 47335-956-88 | Sun Pharmaceutical IndustriesIndia | 22 November 2011 |
| 100 tablet, extended release in 1 bottle, plastic | 29300-155-01 | Unichem LaboratoriesIndia | 15 March 2016 |
| 30 tablet, extended release in 1 bottle, plastic | 29300-155-13 | Unichem LaboratoriesIndia | 15 March 2016 |
| 90 tablet, extended release in 1 bottle, plastic | 29300-155-19 | Unichem LaboratoriesIndia | 15 March 2016 |
| 100 tablet, film coated, extended release in 1 bottle | 57237-114-01 | Rising Pharma Holdings | 30 August 2012 |
| 500 tablet, film coated, extended release in 1 bottle | 57237-114-05 | Rising Pharma Holdings | 30 August 2012 |
| 90 tablet, film coated, extended release in 1 bottle | 57237-114-90 | Rising Pharma Holdings | 30 August 2012 |
| 100 tablet, film coated, extended release in 1 bottle | 64980-746-01 | Rising Pharma Holdings | 1 July 2026 |
| 90 tablet, film coated, extended release in 1 bottle | 64980-746-09 | Rising Pharma Holdings | 1 July 2026 |
| 500 tablet, film coated, extended release in 1 bottle | 64980-746-50 | Rising Pharma Holdings | 1 July 2026 |
| 90 tablet, extended release in 1 bottle | 60505-2850-9 | Apotex | 8 September 2023 |
| 100 tablet, extended release in 1 bottle | 76282-302-01 | Exelan Pharmaceuticals | 2 October 2012 |
| 500 tablet, extended release in 1 bottle | 76282-302-05 | Exelan Pharmaceuticals | 2 October 2012 |
| 1000 tablet, extended release in 1 bottle | 76282-302-10 | Exelan Pharmaceuticals | 2 October 2012 |
| 120 tablet, extended release in 1 bottle | 76282-302-12 | Exelan Pharmaceuticals | 1 December 2022 |
| 90 tablet, extended release in 1 bottle | 76282-302-90 | Exelan Pharmaceuticals | 1 January 2019 |
| 30 tablet, extended release in 1 bottle, plastic | 63629-9155-1 | Bryant Ranch Prepack | 29 April 2022 |
| 60 tablet, extended release in 1 bottle, plastic | 63629-9155-2 | Bryant Ranch Prepack | 29 April 2022 |
| 90 tablet, extended release in 1 bottle, plastic | 63629-9155-3 | Bryant Ranch Prepack | 29 April 2022 |
| 120 tablet, extended release in 1 bottle, plastic | 63629-9155-4 | Bryant Ranch Prepack | 29 April 2022 |
| 30 tablet, extended release in 1 bottle | 71335-2146-1 | Bryant Ranch Prepack | 3 April 2024 |
| 60 tablet, extended release in 1 bottle | 71335-2146-2 | Bryant Ranch Prepack | 3 April 2024 |
| 90 tablet, extended release in 1 bottle | 71335-2146-3 | Bryant Ranch Prepack | 30 January 2023 |
| 120 tablet, extended release in 1 bottle | 71335-2146-4 | Bryant Ranch Prepack | 3 April 2024 |
| 100 tablet, extended release in 1 bottle | 71335-2146-5 | Bryant Ranch Prepack | 3 April 2024 |
| 30 tablet, film coated, extended release in 1 bottle | 71335-2578-1 | Bryant Ranch Prepack | 6 February 2025 |
| 60 tablet, film coated, extended release in 1 bottle | 71335-2578-2 | Bryant Ranch Prepack | 6 February 2025 |
| 90 tablet, film coated, extended release in 1 bottle | 71335-2578-3 | Bryant Ranch Prepack | 6 February 2025 |
| 120 tablet, film coated, extended release in 1 bottle | 71335-2578-4 | Bryant Ranch Prepack | 6 February 2025 |
| 100 tablet, film coated, extended release in 1 bottle | 71335-2578-5 | Bryant Ranch Prepack | 6 February 2025 |
| 90 tablet, extended release in 1 bottle | 72162-1449-9 | Bryant Ranch Prepack | 16 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 12 June 2003 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Alfuzosin 10 mg extended-release tablet.
Other strengths and forms of Alfuzosin
Clinical summary
Alfuzosin is an alpha-adrenergic blocker indicated for the treatment of signs and symptoms of benign prostatic hyperplasia, among other approved uses. It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Alfuzosin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AlfuzosinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Uroxatral prescribing information (Advanz Pharma) · U.S. National Library of Medicine, DailyMed
Need Alfuzosin 10 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.